These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35228386)

  • 21. Identification of an Adduct Impurity of an Active Pharmaceutical Ingredient and a Leachable in an Ophthalmic Drug Product Using LC-QTOF.
    Gollapalli R; Singh G; Blinder A; Brittin J; Sengupta A; Mondal B; Patel M; Pati B; Lee J; Ghode A; Kote M
    J Pharm Sci; 2019 Oct; 108(10):3187-3193. PubMed ID: 31226425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural elucidation of a dimeric impurity in the process development of ceftolozane using LC/HRMS and 2D-NMR.
    Liao J; Sheng H; Saurí J; Xiang R; Martin G
    J Pharm Biomed Anal; 2019 Sep; 174():242-247. PubMed ID: 31181486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis and evaluation of the impurity of felodipine and its tablets].
    Zhang N; Yu LJ; Li J; Tong JW; Meng J; Zhang QM; Shi YQ
    Yao Xue Xue Bao; 2012 Feb; 47(2):223-8. PubMed ID: 22512035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    Anal Bioanal Chem; 2012 Nov; 404(8):2203-22. PubMed ID: 22986987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative 1H NMR: development and potential of a method for natural products analysis.
    Pauli GF; Jaki BU; Lankin DC
    J Nat Prod; 2005 Jan; 68(1):133-49. PubMed ID: 15679337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accurate and Precise External Calibration Enhances the Versatility of Quantitative NMR (qNMR).
    Nishizaki Y; Lankin DC; Chen SN; Pauli GF
    Anal Chem; 2021 Feb; 93(5):2733-2741. PubMed ID: 33481571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the purity of pharmaceutical reference materials by 1H NMR using the standardless PULCON methodology.
    Monakhova YB; Kohl-Himmelseher M; Kuballa T; Lachenmeier DW
    J Pharm Biomed Anal; 2014 Nov; 100():381-386. PubMed ID: 25215441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L; Mao B; Reamer R; Novak T; Ge Z
    J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Structural Elucidation of New Process Impurity in Testosterone.
    Gupte V; Luthra U; Desai N
    J Chromatogr Sci; 2018 May; 56(5):403-408. PubMed ID: 29554236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clarification of the USP compendial procedure for phenoxybenzamine hydrochloride via updating impurity profiles.
    Xu Q; Min D; Petr R; Parikh V; Tan S
    J Pharm Biomed Anal; 2020 Nov; 191():113618. PubMed ID: 32942108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.
    Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S
    J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Kaur A; Prakash R; Ali A
    Talanta; 2018 Feb; 178():1001-1005. PubMed ID: 29136787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk assessment report of potential impurities in cetirizine dihydrochloride.
    Leistner A; Haerling S; Kreher JD; Becker I; Jung D; Holzgrabe U
    J Pharm Biomed Anal; 2020 Sep; 189():113425. PubMed ID: 32599488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of four major diterpenoids in Andrographis paniculata by 1H NMR and its application for quality control of commercial preparations.
    Yang M; Wang J; Kong L
    J Pharm Biomed Anal; 2012 Nov; 70():87-93. PubMed ID: 22738787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Industrial approaches and consideration of clinical relevance in setting impurity level specification for drug substances and drug products.
    Pokar D; Rajput N; Sengupta P
    Int J Pharm; 2020 Feb; 576():119018. PubMed ID: 31911117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of d-Cycloserine Impurities in Pharmaceutical Dosage Forms: Comparison of the International Pharmacopoeia HPLC-UV Method and the DOSY NMR Method.
    Makuc D; Švab Ž; Naumoska K; Plavec J; Časar Z
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32272592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combating Alcohol Adduct Impurity in Immunosuppressant Drug Product Manufacturing: A Scientific Investigation for Enhanced Process Control.
    Sekar V; Vedhachalam D; Vb A; Sivaraman S; Janakarajan V; Sethuraman S; Shiroor SG; Geoffroy JM
    Pharm Res; 2024 May; 41(5):983-1006. PubMed ID: 38561580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative NMR spectroscopy--applications in drug analysis.
    Holzgrabe U; Deubner R; Schollmayer C; Waibel B
    J Pharm Biomed Anal; 2005 Aug; 38(5):806-12. PubMed ID: 15893899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and relative response factor determination of process related impurity in Naproxen by nuclear magnetic resonance spectroscopy.
    Iqbal MY; Rao KM; Sridhar G; Raju PP; Deshpande GR; Babu JM
    J Pharm Biomed Anal; 2011 Nov; 56(3):484-90. PubMed ID: 21782369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Chemical Profiling of Commercial Glyceride Excipients via
    Saraf I; Kushwah V; Weber H; Modhave D; Yeoh T; Paudel A
    AAPS PharmSciTech; 2020 Dec; 22(1):11. PubMed ID: 33270172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.